Pregnancy associated increase in mRNA for soluble D-factor/LIF receptor in mouse liver  by Tomida, Mikio et al.
Volume 334, number 2, 193-197 FEBS 13241 November 1993 
© 1993 Federation ofEuropean Biochemical Societies 00145793/93l$6.00 
Pregnancy associated increase in mRNA for soluble 
D-factor/LIF receptor in mouse liver** 
Mikio Tomida*, Yuri Yamamoto-Yamaguchi ,  Motoo  Hozumi 
Department of  Chemotherapy, Saitama Cancer Center Research Institute, Ina-machi, Kitaadachi-gun, Saitama 362, Japan 
Received 2 September t993 
We examined the distribution of mRNAs for differentiation-stimulating factor (D-factor)/leukemia inhibitory factor (LIF) receptor in various 
mouse tissues by Northern blotting. A mouse cDNA fragment encoding the D-factor eceptor was prepared by the RT-PCR method using human 
cDNA sequences a  primers. The smallest mRNA (3 kb) was present in the liver, but not detectable in other tissues examined. Larger mRNAs 
(5 and 10 kb) were present in the placenta nd the M1 cells, and also detectable in the liver, kidney, heart, lung, brain and embryos. Expression 
of 3 kb mRNA in the liver increased uring pregnancy, being 20 times the initial level on day 15. D-factor eceptor cDNAs were isolated from 
a cDNA library prepared from the liver of a pregnant mouse. Most of the cDNA clones encoded a soluble receptor. A cDNA probe specific for 
the cellular eceptor did not hybridize with 3 kb mRNA in the liver. These results uggest that 3 kb mRNA encodes a soluble D-factor eceptor 
and that the liver is the primary site of synthesis of this soluble receptor. 
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1. INTRODUCTION 
D-factor/LIF was purified and cloned as a cytokine 
inducing differentiation of mouse myeloid leukemic 
M1-T22 cells into macrophages [1-3]. It was also found 
to inhibit the proliferation of freshly isolated leukemic 
blast cells from acute myeloblastic leukemia patients [4]. 
D-Factor has a wide variety of biological activities be- 
sides actions on normal and leukemic hematopoietic 
cells [5,6]. It regulates the differentiation of embryonic 
stem cells, neural cells, hepatocytes, adipocytes, osteo- 
blasts and kidney epithelial cells and the proliferation 
ofmyoblasts, primordial germ cells and aortic endothe- 
lial cells. Although its physiological roles have not yet 
been confirmed, D-factor has been suggested to play an 
important role in development of the mouse. It inhibits 
the differentiation of embryonic stem cells and main- 
tains them in a pluripotent state [7,8]. Developmental 
expression of the D-factor gene has been detected in 
preimplantation blastocysts and in extra-embryonic t s- 
sues and placenta [9]. Stewart et al. [10] developed mice 
lacking the D-factor gene and showed that blastocyst 
implantation depends on expression of D-factor in the 
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uterine ndometrial g ands. On the other hand, overex- 
pression of D-factor cDNA in chimeric embryos inhib- 
ited gasturation [11]. We found that a D-factor-binding 
protein is present in mouse serum and that it increases 
transiently during pregnancy. It inhibits the biological 
activity of D-factor by blocking its binding to receptors 
on the target cells [12]. Therefore, this D-factor-binding 
protein may regulate the action of D-factor during em- 
bryonic development ofmice. It may block the systemic 
effect of D-factor on various tissues of the mother. 
cDNA for the human D-factor receptor and cDNA for 
the mouse soluble receptor were isolated, but nucleotide 
sequences of the mouse soluble receptor and the cellular 
receptor have not yet been reported [5,13]. Layton et al. 
[14] purified the D-factor-binding protein from mouse 
serum, analyzed its amino acid sequence and showed 
that it is a soluble D-factor receptor. In this study, we 
examined site of synthesis of mRNA for the soluble 
D-factor receptor in mice. 
2. MATERIALS AND METHODS 
2.1. Isolation of RNA 
Total RNAs were isolated from mouse tissues or mouse myeloid 
leukemic M 1-T22 cells (5 x 106) by a single-step isolation method [15]. 
Pregnant and nonpregnant ICR mice, 12 weeks old, were purchased 
from CLEA Japan, Tokyo. The day of appearance of a vaginal plug 
was designated as day 0. 
2.2. eDNA probe 
Based on the published cDNA sequence of the human D-factor 
receptor [13], a sense primer (residues 2126-2160) and an antisense 
primer (residues 2729-2748) were synthesized. By use of cDNA pre- 
pared from poly(A) ÷ mRNA of mouse M1-T22 cells, the 568 bases 
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cDNA between the two primers was amplified by PCR [16] (30 cycles 
consisting of 1 min at 95°C (denaturation), 1 min at 45°C (annealing) 
and 1 min at 63°C (extension)). The amplified product was subcloned 
into a pCR 1000 vector (Invitrogen). The subcloned insert was se- 
quenced with a the Sequenase v rsion 2.0 kit (United States Biochem- 
ical). A high degree of homology (83% nucleotide sequence identity) 
was found between this cDNA fragment and human cDNA encoding 
the extracellular domain and the transmembrane domain of the D- 
factor receptor. The first 184 nucleotides of the cDNA are identical 
with those of mouse cDNA encoding the soluble receptor isolated in 
this work. Downstream from residue 185 there is a sequence specific 
to the cellular receptor including a SacI restriction site. The SacI 
fragment (about 300 bp) was used to detect mRNA and cDNA for the 
cellular receptor. 
2.3. Northern blot analysis 
Total RNAs (30pg/lane) were separated on 0.8% agarose-formalde- 
hyde gel and transferred tonitrocellulose membranes (Schleicher and 
Schuell). The membranes were prehybridized in 5 × SSC (standard 
saline citrate) containing 50 mM sodium phosphate, 1 x Denhardt's 
solution, 50% formamide and 250/lg/ml of sonicated-denaturated 
herring sperm DNA at 42°C for 3 h and then hybridized with a 
32P-labeled fragment of mouse D-factor receptor cDNA or fl-actin 
probe (Oncogene Science) in the same solution at 42°C for 16 h. The 
membranes were washed twice with 2 × SSC at room temperature and 
then with 0.1 × SSC containing 0.1% SDS at 65°C for 30 min. Autora- 
diography was performed using a bioimage analyzer, Fujix BAS 2000. 
2.4. eDNA cloning 
Poly(A) ÷ RNA was prepared from the liver of a mouse on day 13 
of pregnancy. A cDNA library (7.2 x 105 independent clones) was 
constructed using a cDNA Synthesis System, eDNA Cloning System 
2gtl0 (Amersham) and Super Script RT (Gibco BRL). The cDNA 
library was screened by plaque hybridization using a 0.6 kb cDNA 
fragment as a probe. Many positive clones were detected and 7 were 
analyzed by subcloning into PUC 18 or pGEM-7Zf (Promega). Dou- 
ble-stranded plasmid DNA was sequenced by the dideoxynucleotide 
chain termination method, cDNA clones encoding the cellular recep- 
tor were isolated from the same Agtl0 plates as used previously. The 
membranes that hybridized with 0.6 kb eDNA were washed with 
0.1 × SSC containing 0.1% SDS at 90°C for 20 min, and then hybrid- 
ized with the 0.3 kb cDNA probe as described. 
3. RESULTS AND DISCUSSION 
3.1. Pregnancy associated increase in mRNA for D-fac- 
tor receptor in the liver and placenta 
Using cDNA fragment encoding the extracellular do- 
main and the transmembrane domain of the mouse D- 
factor receptor, we examined the distribution of the 
mRNA in various mouse tissues, mRNA (3 kb) was 
detected in the liver of nonpregnant mice. This sized 
mRNA was abundant in the liver from day 13 of preg- 
nancy (Fig. 1). The placenta nd mouse myeloid leuke- 
mic M1 cells contained 5 kb and 10 kb mRNAs. On 
longer exposure of autoradiographs, 5 kb and 10 kb 
mRNAs were detected in the liver, brain, heart, kidney, 
lung and embryos (data not shown). These results are 
consistent with previous reports that radiolabeled D- 
factor binds to cells from various tissues [15,16]. 
Next, we examined the change of expression of 
mRNA for the D-factor receptor during pregnancy. 
Fig. 2 shows Northern blot analyses of RNAs from 
pregnant mouse livers. The levels of mRNA were quan- 
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Fig. 1. Northern blot analysis of D-factor receptor mRNA. Total 
RNAs (30 ~tg/lane) from various tissues of a mouse on day 13 of 
pregnancy and MI-T22 cells were electrophoresed in 0.8% agarose- 
formaldehyde g l and then hybridized sequentially with a 32p-labeled 
0.6 kb fragment of mouse D-factor eceptor cDNA (a) and fl-actin 
(b) probes. 
titated with a bioimage analyzer (Fig. 3). Expression of 
the 3 kb mRNA in liver increased uring pregnancy to 
20 times the initial level (mean of 6 experiments) on days 
13 15, and then decreased. We have reported that a 
single class of D-factor-binding protein (Kd = 10 nM) is 
present in mouse serum and that it increases in the late 
stage of pregnancy [12]. This binding protein was shown 
to be a soluble form of the cellular eceptor for D-factor 
by Layton et al. [14]. The pregnancy-related change in 
D-factor eceptor mRNA is parallel with change in level 
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Fig. 2. Expression of mRNA for D-factor receptor in liver during 
pregnancy. Total RNAs (30/ag/lane) isolated from the liver of mice 
on the indicated ays of pregnancy were analyzed using 0.6 kb 
D-factor eceptor eDNA (a) and fl-actin (b) probes. 
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Fig. 3. Expression of mRNA for D-factor eceptor in the liver (a) and 
placenta (b) during pregnancy. Total RNA from the liver or placenta 
of mice on the indicated ays of pregnancy were subjected to Northern 
blot analysis. Relative radioactivities were measured with a bioimage 
analyzer. 
of the soluble receptor protein in mouse serum [12]. In 
the placenta, in contrast o the liver, 5 kb mRNA con- 
tinued to increase during pregnancy (Fig. 3b). 
3.2. Cloning of cDNA encoding soluble D-factor recep- 
tor 
We prepared a cDNA library from the liver of a 
pregnant mouse and detected many positive clones 
(about 40 clones/2 x 104 clones) with a 0.6 kb cDNA 
probe (Fig. 4A). All 7 clones examined were cDNA 
clones for the soluble receptor, because they had a stop 
codon before the transmembrane domain. The nucleo- 
tide sequence and predicted amino acid sequence of the 
longest clone (2551 bases) is shown in Fig. 4B. The 
amino acid sequence is identical to that reported by 
Gearling et al. [13]. The nucleotide sequence which is 
specific to the cellular eceptor was found by comparing 
the sequence of cDNA for the soluble receptor with that 
of the 0.6 kb cDNA fragment prepared by the RT-PCR 
method, cDNA clones for the cellular receptor were 
identified by rehybridization with cDNA probe for the 
cellular receptor of the same membrane used previ- 
ously. The number of cDNA clones for the cellular 
receptor was about 80 times less than that for the solu- 
ble receptor in the cDNA library. We analyzed the 
cDNAs of 8 clones. Although full-length of cDNA has 
not yet been obtained, the cDNA for the cellular recep- 
tor was more than 5 kb. When RNAs were analyzed 
using the cDNA probe specific to the cellular receptor, 
bands of 5 kb and 10 kb mRNA were clearly seen but 
the 3 kb band was faint. These results suggest hat 3 kb 
mRNA encodes the soluble receptor and that 5 kb and 
10 kb mRNAs correspond to the cellular receptor. 
These RNA species may represent alternately spliced 
transcripts, because all three mRNAs were detected 
with the cDNA probe derived from the noncoding 3' 
portion of the soluble receptor (data not shown). Al- 
though expression of 3 kb mRNA in various tissues 
other than the liver was not clear, we obtained cDNA 
clones for the soluble receptor from a cDNA library 
prepared from myeloid leukemic M1 cells. This result 
suggests that production of the soluble receptor is not 
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Fig. 4. D-factor eceptor cDNA. (A) Schematic representation of human D-factor/LIF receptor cDNA (HLIFR; [13]), 0.6 kb mouse cDNA (PCR 
product), and mouse cDNA for soluble D-factor eceptor (MSDR). The coding region is boxed. SS, signal sequence; EC, extracellular region; TM, 
transmembrane domain; IC, intracellular region. (B) Nucleotide and deduced amino acid sequences of the mouse cDNA for soluble D-factor 
receptor. The conserved cysteine residues and the WS motif commonly seen in the cytokine receptor family are boxed. Presumed mRNA processing 
signals (AATAAA) are underlined. 
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M A A Y S W W R Q P S W M V D N K R S R M T P N L P W g L S 30 
TTAGAGAcAACAAACGTTAAAATTCcAGCTCTTTCACCTGGTGATCACGAAGTCAcAATAAATTATcT~ATGGCTTTCAGAGTAAATTC 431 
L E T T N V K I P A L S P G D H E V T I N Y L N G F Q S K F 120 
ACGTTGAATGAAAAAGATGTC TCTTTAATTCCAGAGAC TCCCGAGATCCTGGATTTGTCTGC TGAC TTCTTCACC TCCTCCTTACTAC TG 521 
T L N E K D V S L I P E T P E I L D L S A D F F T S S L L L 150 
A-AGTGGAACGACAGAGGGTC GCTCTGCC TCACCCCTCCAATGCCACCTGGGAGATTAAGGTTCTACAGAATCCAAGGACGGAACCAG TA 611 
K W N D R G S A L P  HP  S N A T W E  I K V L Q N P R T E P V  180 
GCACTCGITTACTCAACACAATGCTGAGTGGTAAAGATACCGTTCAGCACTGGAAC T~ACCTCAGACCTGCCC TTGCAATGTGCCACT 701 
A L V L L N T M L S G K D T V Q H W N W T S D L P L Q C A T 210 
TG GATACGTAATACAGAGAC TAATG T T TTTC C TCAAGACAAAG TG G TGCTC GCAGGC TCAAACATGAC AATT TG T TGTATGAG TC CAACG 881 
W I R N T E T N V F P Q D K V V L A G N M T I C C M S P 270 
~GTGCTTTCA~ACAGATCGGCAATACCC TTCG TC C ~ TCA~'~2CATC~ TACG~C~CCGTTGCGATCCATATCCTG~I~CATCCCC 971 
K V L S G Q I G N T L R P L I H L Y G Q T V A I H I L N I 300 
G T TTC TG~C AG TG GCAC/~CATC ATT T TC ATCACAGACGAC GATGTG TACGG~C GG TGGTC T T'I~CAGGC TATCC TC CCGAT G TT 1061 
V S E N S G T N I F I T D D D V Y G T V V F A G Y P P D 330 
AATAC AGAATACACCC TGT TTGAAAGCAT T TCAGGAAAATC GGCAG TATTTC ACAGGATTGAAGGAC TTACAAACGAGAC TACC G G T TA 1241 
N T E Y T L F E S S G K S A V F H R E G L T N E T Y R 390 
GGCGTGCAAATGCATC CGGCC AAGAAATCCATAAC TTCACCC TGACTGGTCGCAATC AC TGGGGCAGGCACAG TCAGCAG TGG TCATC 1331 
G V Q M H P G Q E H N F T L T G R N P L G Q A Q S A V V 420 
AATG TGACTGAGAGAG T~CTCC TCATGATCC GAC T TCG TTGAAAG TGAAGGACATCAAT CAACAGT TGTTACAT TTTC TTGGTATT TA 1421 
N V T E R V A P H D P T S L K V K D I N S T V V T F S W Y 450 
C CAG GAAATT TTACAAAGATTAATC TT TTATG TCAAAT~AAATTTG TAAAG C TAAT TCCAAGAAAGAAG TGAGGAATGCC ACAATC AGA 1511 
P G N F T K I N L L C Q I E I C K A N S K K E V R N A T I 480 
GGAGCCGAGGAT'I~21~.CTI` AcCATGTT~2TGTAGAc1~TT1~'A~.TCCATACAC'I~3CATAcACTTTCCGGGTTcGTTGT'~2TTCC1~GACT 1601 
G A E D S T Y H V A V D K L N P Y T A T F R V R C S S K 510 
AG TTC TGATGGAA~-%-%A~TAATCGTCTACTGGAAGCC TTTACCTATTAATGAAGC TAATGGAAAAATAC TTTCCTACAATGTTTCGTGT 1781 
S S D G K N L I V W K P L P I N E A N G K I L S Y N V S 570 
TCAT TGAACGAGGAGACACAG TCAG T TTTGGAGATC TTCGATC C TCAACACAGAGC AG AGATACAGC TTAG TA~2~ATGAC TACATCATC 1871 
S L N E E T Q S V L E I F D P Q H R A E I Q L S K N D Y I 680 
AGTGTGGTGGCAAGAAATTCTGCTGGC T ATCACCACCTTCGAAAATAGCTAGTATGGAAATCCCAAATGATGACATCACAGTAGAGCAA 1961 
S V V A R N S A G S S P P S K I A S M E I P N D D I T V E Q 630 
G~GGTGGGGCTAGGAAACAGGATCTT~TCACCTGGCGTCACGACCCCAA~ATGACTTGTGA~TA~GTAATTAAATGGTGCAACTCATCT 2051 
A V G L G N R I F L T W R H D P N M T C D Y V I K W C N S 660 
CGGTCTGAGCCCTGCCTCC TGGACTGGAGA~AGGTTCC TTCAAACAGCACGGAGAC TG TCATAGAGTCTGATCAGTTTCAGCCAGGAGTA 2141 
R S E P C L L D W R K V P S N S T E T V I E S D ~Q F Q P G V 690 
AGATACAAC TTTTACC TCTATGGG TGC AC TAAC CAGGGATACCAAC TG TTACG TTC C ATAATTGGATACG TAGAAGAACTGGAAGC TTAA 2231 
R Y N F Y L Y G C T N Q G Y Q L L R S I G Y V E E L E A * 719 
AAACTTGGAAATGTAT•CAGGCcTAACACcAGAGAGGGGAGTATCCcTGAAGTCTGTTTGAGCGGTCACTTAAAATATGCGGCACATGGG 2321 
G GGC TGGAGAGATGGCACCGAC TGC TC TTC CAG AGG TC CTG AGTTCAATTCCCAG CAACCACATGGTGAC TC ACAAC CATCTG TAATG GG 2411 
T " " 2522 
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restricted to the liver. However, expression of mRNA 
for the soluble receptor is most abundant  in liver, indi- 
cating that the liver is the primary source of the circulat- 
ing soluble receptor for D-factor. 
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